logo

Diasorin | Sustainability & Chart

IT0003492391

Basic information on Diasorin

Location: Italy

Industry: Health Services

Website

knob-globe
59%

Impact Score

Description Diasorin

DiaSorin is a biotechnology company specializing in the development, production, and distribution of diagnostic systems and tests for a variety of medical conditions.

Diasorin Sustainability Performance

Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare Diasorin with ...

Diasorin

?

Impact Score

knob-globe
59%
knob-globe
0%
Climate
Society
Gender

Sources of sustainability performance

MetricValueUnitYearPDF NamePDF Page
CEO Pay Ratio
Total wages paid383 086€ thousands)2025Financial Statements 31.12.2025.pdf294
Number of employees3 272people2025Financial Statements 31.12.2025.pdf211
CEO nameCarlo Rosa2025Financial Statements 31.12.2025.pdf74
CEO salary1 872 7722025Diasorin_Remunerazione_2026_ENG.pdf30
Employee Turnover Rate
Employee turnover11,95%2025Financial Statements 31.12.2025.pdf211
Gender Pay Gap
Unadjusted gender pay gap15,17gap2025Financial Statements 31.12.2025.pdf221
Glass Ceiling
Women in workforce1 438people2025Financial Statements 31.12.2025.pdf211
Women in management28%2025Financial Statements 31.12.2025.pdf220
Number of employees3 272people2025Financial Statements 31.12.2025.pdf211
Greenhouse Gas Emissions
Scope 2 emissions, location based14 447tCO₂eq2025Financial Statements 31.12.2025.pdf194
Scope 1 emissions4 184tCO₂eq2025Financial Statements 31.12.2025.pdf194
Number of employees3 272people2025Financial Statements 31.12.2025.pdf211
Harassment and Discrimination at the Workplace
Retaliation safeguardsYes2025diasorin_group_-_ethical_code_and_guidelines_2 (1).pdf35
Anti-discrimination policyYes2025Financial Statements 31.12.2025.pdf218
Confidentiality mechanismsYes2025Financial Statements 31.12.2025.pdf207
Incident notification mechanismYes2025Financial Statements 31.12.2025.pdf222
Renewable Energy
Total renewable energy consumption13%2025Financial Statements 31.12.2025.pdf192
Supply Chain
Scope 2 emissions, location based14 447tCO₂eq2025Financial Statements 31.12.2025.pdf194
Scope 3 emissions96 847tCO₂eq2025Financial Statements 31.12.2025.pdf194
Number of employees3 272people2025Financial Statements 31.12.2025.pdf211
Scope 1 emissions4 184tCO₂eq2025Financial Statements 31.12.2025.pdf194
Recycling and Recovery of Waste
Waste recycled38%2025Financial Statements 31.12.2025.pdf204
Women on Board
Women on supervisory board6people2025Financial Statements 31.12.2025.pdf126
Supervisory board size13people2025Financial Statements 31.12.2025.pdf126
Women in Management
Women in management28%2025Financial Statements 31.12.2025.pdf220
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

logo
© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev